
A new research found that deaths from drug overdose have surged across the US to record levels.
New figures released by the Centers for Disease Control and Prevention (CDC) shows there were 47,055 deaths from drug overdose across the country in 2014.
Advertisement
‘The CDC report stated that in 2014, opioids, which are primarily prescription pain relief drugs and heroine, counted for 28,647 deaths.’
Tweet it Now
The count includes deaths involving powerful painkillers, sedatives, heroin, cocaine and other legal and illicit drugs. The report said more people die a year from drug related overdoses in the US than they do from road traffic accidents, where fewer than 33,000 of crashes end in fatalities.
Lead researcher Rose Budd said that these findings indicate that the opioid overdose epidemic is worsening.
The report says, "There is a need for continued action to prevent opioid abuse, dependence, and death, improve treatment capacity for opioid use disorders, and reduce the supply of illicit opioids, particularly heroin and illicit fentanyl."
Source: ANI
The report says, "There is a need for continued action to prevent opioid abuse, dependence, and death, improve treatment capacity for opioid use disorders, and reduce the supply of illicit opioids, particularly heroin and illicit fentanyl."
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News

The International Space Station will be used to carry out experiments seeking to improve understanding of incurable child brain tumors and the muscle aging process.

How many people in the UK have misophonia? In a representative sample study, most people had at least some irritation upon hearing trigger sounds.

Routine eye-checkups and mass screenings enable early diagnosis and treatment of glaucoma. Late-stage glaucoma diagnosis leads to blindness.

Brain plasticity following blindness leads to superior ability in sensing signals from the heart, which has implications for bodily awareness and emotional processing.

A group of scientists were awarded £1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.